{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:00:41Z","timestamp":1790128841658,"version":"4.0.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Phys Med Rehabil"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>The aim of the study was to investigate the safety and efficacy of onabotulinum toxin A injection to the salivary glands under ultrasound guidance for the treatment of sialorrhea in patients with spinal muscular atrophy type I.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design<\/jats:title>\n            <jats:p>Prospective case series with four patients with spinal muscular atrophy type I who received onabotulinum toxin A injection to parotid and submandibular glands for sialorrhea as part of clinical care. All four patients received validated surveys for measuring drooling, including objective measures of number of bib changes, and number of mouth wipes before injection and 4\u20136 wks after injection. Research was limited to survey completion. Scales included the Drooling Severity and Frequency Scale and the Drooling Impact Scale as well as a new scale used in our clinic, the Posterior Drooling Scales looking at coughing\/choking and number of aspiration pneumonias.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>There were no adverse events. All four patients showed clinically significant improvements. The improvement in drooling using the Drooling Impact Scale was statistically significant (paired <jats:italic toggle=\"yes\">t<\/jats:italic> test, <jats:italic toggle=\"yes\">t<\/jats:italic> = 3.243, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.048). All patients improved with number of mouth wipes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Ultrasound-guided onabotulinum toxin A injections to the salivary glands may be a safe and effective method of decreasing drooling in patients with spinal muscular atrophy type I.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/phm.0000000000000989","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T16:18:46Z","timestamp":1529425126000},"page":"873-878","source":"Crossref","is-referenced-by-count":15,"title":["Onabotulinum Toxin A Injections Into the Salivary Glands for Spinal Muscle Atrophy Type I"],"prefix":"10.1097","volume":"97","author":[{"given":"Hannah Aura","family":"Shoval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Antelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Alejandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heakyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20230922","first-page":"2120","article-title":"Spinal muscular atrophy","volume":"371","year":"2008","journal-title":"Lancet Semin 2120"},{"key":"bib2-20230922","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/0883073807305788","article-title":"Consensus statement for standard of care in spinal muscular atrophy","volume":"22","year":"2007","journal-title":"J Child Neurol"},{"key":"bib3-20230922","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jpeds.2011.08.016","article-title":"Prevalence and risk factors for feeding and swallowing difficulties in spinal muscular atrophy types II and III","volume":"160","year":"2012","journal-title":"J Pediatr"},{"key":"bib4-20230922","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.nmd.2008.05.008","article-title":"Survival in SMA type I: a prospective analysis of 34 consecutive cases","volume":"18","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"bib5-20230922","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/practneurol-2016-001515","article-title":"Management of oral secretions in neurological disease","volume":"17","year":"2017","journal-title":"Pract Neurol"},{"key":"bib6-20230922","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nrneurol.2010.149","article-title":"Use of botulinum toxin in the neurology clinic","volume":"6","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"bib7-20230922","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3390\/toxins5051010","article-title":"Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins","volume":"5","year":"2013","journal-title":"Toxins (Basel)"},{"key":"bib8-20230922","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/000992289803700805","article-title":"Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy","volume":"37","year":"1998","journal-title":"Clin Pediatr (Phila)"},{"key":"bib9-20230922","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/archpedi.154.12.1214","article-title":"Treatment of sialorrhea with glycopyrrolate: a double-blind, dose-ranging study","volume":"154","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"key":"bib10-20230922","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/j.ijporl.2015.09.029","article-title":"Salivary botulinum toxin injection may reduce aspiration pneumonia in neurologically impaired children","volume":"79","year":"2015","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"bib11-20230922","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5535\/arm.2017.41.1.51","article-title":"Accuracy of ultrasound-guided and non-ultrasound-guided botulinum toxin injection into cadaver salivary glands","volume":"41","year":"2017","journal-title":"Ann Rehabil Med"},{"issue":"suppl","key":"bib12-20230922","first-page":"109","article-title":"Botulinum toxin assessment, intervention and aftercare for paediatric and adult drooling: international consensus statement","volume":"17","year":"2010","journal-title":"Eur J Neurol"},{"key":"bib13-20230922","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.ijporl.2014.08.041","article-title":"Botulinum toxin A for children with salivary control problems","volume":"78","year":"2014","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"bib14-20230922","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1469-8749.2012.04428.x","article-title":"Accurate assessment of drooling severity with the 5-minute drooling quotient in children with developmental disabilities","volume":"54","year":"2012","journal-title":"Dev Med Child Neurol"},{"key":"bib15-20230922","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1542\/peds.2003-1104-L","article-title":"Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial","volume":"114","year":"2004","journal-title":"Pediatrics"},{"key":"bib16-20230922","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02412423","article-title":"Three treatment approaches and clinical factors in the reduction of drooling","volume":"3","year":"1988","journal-title":"Dysphagia"},{"key":"bib17-20230922","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ijporl.2015.05.010","article-title":"Drooling quantification: correlation of different techniques","volume":"79","year":"2015","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"bib18-20230922","article-title":"The Drooling Impact Scale: a measure of the impact of drooling in children with developmental disabilities","volume":"52","year":"2010","journal-title":"Dev Med Child Neurol"},{"key":"bib19-20230922","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/pch\/4.6.406","article-title":"Drooling in children","volume":"4","year":"1999","journal-title":"Paediatr Child Health"},{"key":"bib20-20230922","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S2213-2600(16)30151-5","article-title":"Long-term non-invasive ventilation in children","volume":"4","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"suppl","key":"bib21-20230922","first-page":"S245","article-title":"Special considerations in the respiratory management of spinal muscular atrophy","volume":"123","year":"2009","journal-title":"Pediatrics"},{"key":"bib22-20230922","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ppul.10110","article-title":"Spinal muscular atrophy type 1: management and outcomes","volume":"34","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"bib23-20230922","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2012-201964","article-title":"British Thoracic Society guideline for respiratory management of children with neuromuscular weakness","volume":"67","year":"2012","journal-title":"Thorax"},{"key":"bib24-20230922","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.braindev.2007.04.003","article-title":"Successful botulinum toxin treatment of dysphagia in a spinal muscular atrophy type 2 patient","volume":"29","year":"2007","journal-title":"Brain Dev"},{"key":"bib25-20230922","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/WNF.0b013e3181f5329e","article-title":"Systemic weakness after therapeutic injections of botulinum toxin A","volume":"33","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"bib26-20230922","first-page":"319","article-title":"Diffusion of botulinum toxins","volume":"2","year":"2012","journal-title":"Tremor Other Hyperkinet Mov (N Y)"}],"container-title":["American Journal of Physical Medicine &amp; Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002060-201812000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T19:38:06Z","timestamp":1695411486000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002060-201812000-00003"}},"subtitle":["A Prospective Case Series of 4 Patients"],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/phm.0000000000000989","relation":{},"ISSN":["1537-7385","0894-9115"],"issn-type":[{"value":"1537-7385","type":"electronic"},{"value":"0894-9115","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}